Singapore markets open in 1 hour 25 minutes

Ono Pharmaceutical Co., Ltd. (OPHLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
21.56-0.93 (-4.14%)
At close: 09:30AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 11.43B
Enterprise value 10.54B
Trailing P/E 19.24
Forward P/E 13.87
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)4.35
Price/book (mrq)2.44
Enterprise value/revenue 0.03
Enterprise value/EBITDA 0.08

Trading information

Stock price history

Beta (5Y monthly) 0.32
52-week change 3-11.35%
S&P500 52-week change 3-11.63%
52-week high 327.76
52-week low 321.00
50-day moving average 323.58
200-day moving average 324.93

Share statistics

Avg vol (3-month) 3284
Avg vol (10-day) 340
Shares outstanding 5488.31M
Implied shares outstanding 6N/A
Float 8392.99M
% held by insiders 116.05%
% held by institutions 144.37%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.51
Forward annual dividend yield 42.25%
Trailing annual dividend rate 361.00
Trailing annual dividend yield 3271.23%
5-year average dividend yield 4N/A
Payout ratio 430.95%
Dividend date 324 Jun 2018
Ex-dividend date 429 Mar 2023
Last split factor 25:1
Last split date 328 Mar 2016

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 30 Mar 2022
Most-recent quarter (mrq)29 Sept 2022


Profit margin 23.90%
Operating margin (ttm)32.90%

Management effectiveness

Return on assets (ttm)10.53%
Return on equity (ttm)13.93%

Income statement

Revenue (ttm)403.99B
Revenue per share (ttm)822.74
Quarterly revenue growth (yoy)26.80%
Gross profit (ttm)267.85B
EBITDA 150.58B
Net income avi to common (ttm)96.57B
Diluted EPS (ttm)1.52
Quarterly earnings growth (yoy)47.90%

Balance sheet

Total cash (mrq)163.78B
Total cash per share (mrq)335.34
Total debt (mrq)8.29B
Total debt/equity (mrq)1.17
Current ratio (mrq)4.07
Book value per share (mrq)1,442.50

Cash flow statement

Operating cash flow (ttm)102.44B
Levered free cash flow (ttm)64.89B